About Protocols.io
Protocols.io is a company based in Berkeley (United States) founded in 2012. Protocols.io has raised $500 thousand across 3 funding rounds from investors including Lighthouse Capital Management. Protocols.io offers products and services including Protocols.io Platform and Protocols.io Editor. Protocols.io operates in a competitive market with competitors including Causaly, ScienceIO, Collaborative Drug Discovery, Qrativ and Kudos, among others.
- Headquarter Berkeley, United States
- SectorsHealthcare
- Website category Science and Education · Biology
- Emailβ’β’β’β’β’β’β’β’
- Website protocols.io
- Social LinkedIn X Facebook
- Total Equity Funding$500K (USD)
in 3 rounds
- Latest Funding Round$25K (USD), Seed
Jun 2016
- Investors
Products & Services of Protocols.io
Protocols.io offers a comprehensive portfolio of products and services, including Protocols.io Platform and Protocols.io Editor.
Secure system for developing and sharing research methods online.
Tool for creating and editing reproducible research protocols.
Funding Insights of Protocols.io
Protocols.io has successfully raised a total of $500K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $25 thousand completed in June 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $500,000
- Total Rounds 3
- Last Round Seed β $25,000
- First Round $250,000
(Aug 2012)
- Investors Count 1
All 3 funding rounds of Protocols.io with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2016 | $25,000 | Seed | β | β | β |
| Aug 2014 | $225,000 | Seed | β | Lighthouse Capital Management | β |
| Aug 2012 | $250,000 | Seed | β | β | β |
1 investors in total: 1 institutional.
Investors in Protocols.io
Protocols.io has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Lighthouse Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments are directed toward US and Chinese markets. | – | lighthousecapital.cn | Huangpu, China |
Investor details for Protocols.io
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Protocols.io
5 people are tracked at Protocols.io (2 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Lenny Teytelman | Founder And President | Leadership |
Emma Ganley | Director of Strategic Initiatives | Leadership |
Forrest Jordan | Advisor | Team |
Bogdan Bogdanov | Junior Full-Stack Web Developer | Team |
Joe Duncan | Advisor | Team |
Complete people profiles for Protocols.io
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Protocols.io
3 dated milestones of Protocols.io across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Protocols.io is founded.
- Funding First funding round of $250K.
- Funding Latest funding round, Seed, of $25K.
Competitors of Protocols.io
Protocols.io operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Causaly, ScienceIO, Collaborative Drug Discovery, Qrativ and Kudos, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| causaly.com | 2017 | London, United Kingdom | $90.72M | 62 | AI-based data-mining tools for scientific evidence discovery are provided. | |
| science.io | 2020 | Boston, United States | $8M | 22 | Provider of AI solutions transforming medical text into enriched healthcare data | |
| collaborativedrug.com | 2004 | Burlingame, United States | – | 31 | Biological and chemical data are managed securely in a database. | |
| qrativ.bio | 2017 | Cambridge, United States | $8.3M | – | AI based drug purposing platform to identify treatments for rare diseases | |
| growkudos.com | 2013 | Oxford, United Kingdom | $2.5M | 12 | Research communication services are provided to boost visibility and impact. | |
| docphin.com | 2010 | New York, United States | $1M | – | Medical news and research are personalized for physicians. | |
| citelighter.com | 2011 | New York, United States | $6.58M | – | Digital writing solution for K-20 students | |
| longenesis.com | 2017 | Riga, Latvia | $1.19M | 16 | Digital platform for healthcare research and patient engagement | |
| biosymetrics.com | 2015 | New York, United States | $4.88M | – | Provider of a cognitive computing-based biomedical intelligence platform |
Detailed competitors of Protocols.io
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Protocols.io
The website of Protocols.io (protocols.io) receives about 357.9K visits a month and ranks #143,445 among all websites worldwide, #9,245 in Biology.
- Monthly visits357.9K
▲ 9.6% vs previous month
- Unique visitors147.1K
per month
- Global rank#143,445
among all websites
- Category rank#9,245
Science and Education · Biology
- Bounce rate48%
- Pages per visit2.4
- Average visit1 min 34 sec
- DevicesDesktop 53% Β· Mobile 47%
Websites whose visitors overlap most with Protocols.io. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
addgene.org | addgene.org | 100% | – | #84,256 | β |
| biorxiv.org | 99% | 3M | #19,954 | View details | |
| benchling.com | 99% | 1.4M | #36,159 | View details | |
| cell.com | 98% | 5M | #14,619 | View details | |
scisure.com | scisure.com | 97% | – | #907,030 | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for Protocols.io
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Protocols.Io
Complete news archive for Protocols.io
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Protocols.io
10 companies that operate in the same segment as Protocols.io (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Protocols.io
Protocols.io was founded in 2012.
Protocols.io is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.
Protocols.io is a funded company, having raised a total of $500K across 3 funding rounds to date. The company's 1st funding round was a Seed of $250K, raised on Aug 2012.
Protocols.io was founded in 2012 in Berkeley, United States, as a repository for life science clinical trial protocols. The platform is operated within the biotechnology sector, utilizing web and mobile technologies for knowledge discovery and sharing. Protocols are cloned, modified, and discussed by users, while personal protocols are created and collaborative groupsprivate or publicare formed. Reference libraries are uploaded, and recommendations for recent articles are generated based on user activity.
Protocols.io's top competitors include Causaly, ScienceIO and BioSymetrics.
Protocols.io offers Protocols.io Platform and Protocols.io Editor.
Protocols.io has 1 investor. Key investors include Lighthouse Capital Management.
The website of Protocols.io receives about 358 thousand visits a month and ranks #143,445 among all websites worldwide.

